Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma
Apply
Sacituzumab Tirplatin
Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step